• Sab. Feb 22nd, 2025

disease

  • Home
  • A diabetes, heart failure and kidney disease medication (sotagliflozin) is the first of its kind to significantly reduce both heart attacks and strokes

A diabetes, heart failure and kidney disease medication (sotagliflozin) is the first of its kind to significantly reduce both heart attacks and strokes

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and…

CDC Statement on Marburg Cases in Rwanda

CDC is aware of 26 individuals with Marburg virus disease, as confirmed by the Republic of Rwanda Ministry of Health. According to the Ministry, eight of those individuals have died.…

Estrogens play a hidden role in cancers, inhibiting a key immune cell

Estrogens are known to drive tumor growth in breast cancer cells that carry its receptors, but a new study by Duke Cancer Institute researchers unexpectedly finds that estrogens play a…

Blood test can help predict chronic lung disease in preterm babies

A blood test can help predict which preterm babies will go onto develop chronic lung disease, allowing for earlier diagnosis and more targeted treatments, according to a new study. The…

Inflammatory activity of rheumatoid arthritis linked to specific cognitive impairments

The inflammatory activity in the body caused by rheumatoid arthritis is linked to specific cognitive impairments, finds a small comparative study, published in the open access journal RMD Open. These…

Understanding the benefits of GLP-1 drugs beyond obesity

In a Perspective, Daniel Drucker highlights the growing body of evidence that hints at the potential of glucagon-like peptide-1 (GLP-1)-based medications in treating conditions other than diabetes and obesity, including…

When to trust an Artificial Intelligence AI model

Because machine-learning models can give false predictions, researchers often equip them with the ability to tell a user how confident they are about a certain decision. This is especially important…

Artificial intelligence outperforms clinical tests at predicting progress of Alzheimer’s disease

Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer’s disease.…

To regenerate the kidney, please don’t pass the salt

A loss of salt and body fluid can stimulate kidney regeneration and repair in mice, according to a NIH-funded study led by USC Stem Cell scientist Janos Peti-Peterdi and published…

AI: Scientists discover high-risk form of endometrial cancer and how to test for it

A discovery by researchers at the University of British Columbia promises to improve care for patients with endometrial cancer, the most common gynecologic malignancy. Using artificial intelligence (AI) to spot…